发明名称 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
摘要 The invention provides isolated nucleic acids molecules, designated 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 gene has been introduced or disrupted. The invention still further provides isolated 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 proteins, fusion proteins, antigenic peptides and anti-26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
申请公布号 US2007065848(A1) 申请公布日期 2007.03.22
申请号 US20060493347 申请日期 2006.07.26
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 MEYERS RACHEL E.;MACBETH KYLE J.;CURTIS RORY A.;RUDOLPH-OWEN LAURA A.;WEICH NADINE S.;OLANDT PETER J.;TSAI FONG-YING;KAPELLER-LIBERMANN ROSANA;CARROLL JOSEPH M.
分类号 C12Q1/68;A61K38/00;A61K38/43;A61K48/00;C07H21/04;C07K14/705;C12N9/02;C12N9/04;C12N9/10;C12N9/12;C12N9/16;C12N9/48;C12N9/80;C12P21/06;C12Q1/32;G01N33/53 主分类号 C12Q1/68
代理机构 代理人
主权项
地址